Results 281 to 290 of about 65,774 (303)

Intranasal Naloxone Administration. Reply.

The New England journal of medicine, 2021
Rafael, Ortega, Ala, Nozari, William, Baker   +2 more
openaire   +1 more source

Pharmacokinetic and pharmacodynamic study of intranasal and intravenous dexmedetomidine

British Journal of Anaesthesia, 2018
I C K Wong, M G Irwin, V M Yuen
exaly  

A Randomized Controlled Trial of Intranasal Ketamine in Major Depressive Disorder

Biological Psychiatry, 2014
Kyle A B Lapidus, Andrew M Perez, Michael K Parides   +2 more
exaly  

Intranasal Administration of Oxytocin for Induction and Stimulation of Labour

Acta Obstetricia et Gynecologica Scandinavica, 1962
openaire   +2 more sources

Does intranasal dexmedetomidine provide adequate plasma concentrations for sedation in children: a pharmacokinetic study

British Journal of Anaesthesia, 2018
J W Miller
exaly  

Adjunctive intranasal esketamine for major depressive disorder: A systematic review of randomized double-blind controlled-placebo studies

Journal of Affective Disorders, 2020
Kang Sim, Gabor S Ungvári, Yuping Ning   +2 more
exaly  

Nanotransfersomes of carvedilol for intranasal delivery: formulation, characterization and in vivo evaluation

Drug Delivery, 2016
Heba M Aboud, Adel Ahmed Ali, Shahira F El-Menshawe   +2 more
exaly  

Targeted drug delivery to the brain via intranasal nanoemulsion: Available proof of concept and existing challenges

International Journal of Pharmaceutics, 2019
Bappaditya Chatterjee, Bapi Gorain, Pinaki Sengupta   +2 more
exaly  

Intranasal insulin improves memory in humans

Psychoneuroendocrinology, 2004
Christian Benedict, Manfred Hallschmid, Bernd Schultes   +2 more
exaly  

Intranasal oxytocin attenuates the cortisol response to physical stress: A dose–response study

Psychoneuroendocrinology, 2013
Christopher Cardoso, Mark A Ellenbogen, Simon L Bacon   +2 more
exaly